Tern Therapeutics
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.
terntx.comCompany Details
Founded
- 2023
Employees
- Between 2 - 10 employees
Raised
- $15,000,000
Public
- No
Acquired
- No
CEO
Alex M. Bailey, Ph.D.
Founders
- Matthew RosiniAlex M. Bailey, Ph.D.
Company Collections
These are collections Tern Therapeutics is a part of. Click on the collection name to view similar companies.